ReviewJournal of the Pediatric Infectious Diseases Society2025
Toxoplasma gondii and the Brain: Frenemies? Or Just Outright Foes?
Review in Journal of the Pediatric Infectious Diseases Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Toxoplasma gondii is an apicomplexan parasite with an enormous global reach, infecting over a billion people worldwide. An opportunist in humans, T. gondii causes severe disease only in a select few scenarios but is otherwise relatively benign. Through mechanisms that are unclear T. gondii has a propensity to persist in neuronal tissues including the brain and retina, and it is in these sites that it can cause the most severe disease. Disease occurs in those with suppressed immune function, including HIV/AIDS and organ transplant patients. However, infection can also lead to recurrent ocular disease in otherwise healthy individuals, causing temporary vision loss and in the most severe cases, blindness. The propensity for this organism to reside and cause disease in tissues of the central nervous system is of great interest, and here we explore what is known about the neurovirulent outcomes of T. gondii infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.